30,273 results on '"Hematologic diseases"'
Search Results
2. Longitudinal Studies of Patient With FPDMM
3. Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy
4. Gulf Long-Term Follow-Up Study
5. Screening for Hematology Branch Protocols
6. Itacitinib for the Prevention of Graft Versus Host Disease
7. Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
8. Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
9. Investigation of the Genetics of Hematologic Diseases
10. A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
11. AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
12. A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia
13. Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
14. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
15. Gene Therapy Study in Severe Hemophilia a Patients with Antibodies Against AAV5 (GENEr8-AAV5+)
16. Clinical Study of Combined Platelet Transfusion
17. Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
18. National Longitudinal Cohort of Hematological Diseases (NICHE) - CART
19. Study on the Clinical Efficacy of Teclistamab (TECTONIC)
20. Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT) (ACT)
21. A Long-term Follow-up Study in Participants Who Received CTX001
22. Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant from Related or Unrelated Donors for Blood Diseases in Children and Young Adults
23. Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
24. Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study
25. Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation
26. AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation (AlloCare)
27. Autologous Testicular Tissue Transplantation
28. Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems
29. Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
30. Umbilical Cord Blood Transplantation From Unrelated Donors
31. The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
32. A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
33. Joint and Hematologic Disorders of Noonan Syndrome: French Descriptive Cross-sectional Study (NOORHA)
34. A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
35. Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
36. IASO-782 in Autoimmune Hematological Diseases
37. Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Hospitalized Patients
38. Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders (LY-SET-HAPLO)
39. Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
40. Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
41. Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
42. Health Information Technology System ('Roadmap 2.0') in the Context of Hematopoietic Cell Transplantation
43. Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation (CTL-DP 01)
44. Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
45. Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
46. Role of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CNS.
47. Rapid Analysis of Infections by Spectrometry of Exhaled Breath (RAISE)
48. HEME Home Transfusion Program
49. Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies (INTHEMA)
50. Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.